Aurinia Pharmaceuticals
AUPH • NASDAQ • Stock Fundamentals
Aurinia Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kevin C. Tang, with a market cap of $2.0B.
Market Cap$2.0B
Employees300.0
CEOKevin C. Tang
CountryCanada
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsJul 30, 2026 · in a monthBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Aurinia Pharmaceuticals FAQ
Common questions about Aurinia Pharmaceuticals
Aurinia Pharmaceuticals (AUPH) has a market capitalization of $2.0B and trades on NASDAQ.
Aurinia Pharmaceuticals has approximately 300 employees.